ClinicalTrials.Veeva

Menu

TLR-9 Antagonism in Steroid Resistant Optic Neuritis

S

Sudhalkar Eye Hospital

Status

Completed

Conditions

Optic Neuritis

Treatments

Drug: Mycobacterium w.(Mw)-freeze dried extract 0.5ml

Study type

Interventional

Funder types

Other

Identifiers

NCT01424735
21234EH

Details and patient eligibility

About

Although idiopathic steroid resistant optic neuritis is very uncommon, there is no established treatment protocol for such patients. Toll like receptors (TLRs) especially TLR-9 has been shown to play a role in the pathogenesis of optic neuritis. This small case series aims to determine whether immunomodulators directed specifically at TLR-9(i.e. TLR-9 antagonism)play any role in improving the visual function in such patients.

Enrollment

8 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

Unilateral Steroid Resistant Optic Neuritis

Exclusion criteria

  • bilateral optic neuritis
  • Associated Systemic disease
  • Prior treatment received

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

8 participants in 1 patient group

Mw.
Experimental group
Description:
Administration of immunomodulator Mw.
Treatment:
Drug: Mycobacterium w.(Mw)-freeze dried extract 0.5ml

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems